Intas Pharma and Henlius Biotech strengthen oncology partnership for Europe & India markets

Indian firm Intas Pharmaceuticals has entered into an exclusive license agreement with Shanghai Henlius Biotech, Inc. fo...

October 27, 2023 | Friday | News
LianBio inks $350 M deal with Bristol Myers Squibb to provide cardiac drug in China & other Asian markets

LianBio, a biotechnology startup dedicated to bringing innovative medicines to patients in China and other major Asian m...

October 25, 2023 | Wednesday | News
Cyrus K. Mirsaidi steps in as Global CEO of Bridgewest Perth Pharma

Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, has announced that Cyrus K. Mirs...

October 24, 2023 | Tuesday | News
CPHI Annual Report predicts VC capital (re)-entry and contract services growth in 2024

New research from the CPHI Annual Report 2023, launched during CPHI Barcelona, the world’s largest ...

October 24, 2023 | Tuesday | News
Korean firm Celltrion announces business merger for achieving KRW 12 Tn in sales by 2030

South Korea-based Celltrion Group has announced that the merger agreement between Celltrion, Inc. and Celltrion Healthca...

October 23, 2023 | Monday | News
Genexine and KGbio receive market approval for novel long-acting Erythropoietin in Indonesia

Genexine, a publicly-listed clinical-staged Korean biopharmaceutical company, together with PT Kalbe Genexine Biologics ...

October 23, 2023 | Monday | News
Daiichi Sankyo and Merck announce global deal worth billion dollars to develop antibody drug conjugates

Japanese pharmaceutical firm Daiichi Sankyo and US-based life sciences company Merck (known as MSD outside of the United...

October 20, 2023 | Friday | News
Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines

Building upon its sizeable presence in the oncology space in the Association of Southeast Asian Nations (ASEAN) region, ...

October 17, 2023 | Tuesday | News
Singapore-Korea partnership for new ovarian cancer therapy

Singapore-based biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has signed a license deal with Kore...

October 16, 2023 | Monday | News
GSK and Zhifei announce exclusive strategic vaccine partnership in China

British pharmaceutical firm GlaxoSmithKline (GSK) has reached an exclusive agreement with Chongqing Zhifei Biologic...

October 13, 2023 | Friday | News
Taiwanese firm TaiGen Biopharma to develop and commercialise new drug in Malaysia and Singapore

TaiGen Biopharmaceuticals Holdings has announced that TaiGen Biotechnology, a subsidiary company of TaiGen, has signed a...

October 11, 2023 | Wednesday | News
Taiwan approves first and only treatment for rare genetic disorder

CANbridge Pharmaceuticals, a global biopharmaceutical company with a foundation in China, has announced the marketi...

October 10, 2023 | Tuesday | News
KOREA LIFE SCIENCE WEEK 2023 (with KOREA LAB Autumn) to open on November 14

  KOREA LIFE SCIENCE WEEK 2023, where you can grasp the latest research and development technologies and trends in...

October 9, 2023 | Monday | News
Japanese firm Kyowa Kirin to acquire UK-based startup Orchard Therapeutics for $477 M

Kyowa Kirin, a Japan-based global specialty pharmaceutical company and UK-based startup Orchard Therapeutics plc, a glob...

October 6, 2023 | Friday | News
CPHI Middle East opens in 2024 for expanding regional pharma manufacturing base

A new event for global pharma will launch in 2024 with CPHI Middle East opening at the Riyadh Exhibition and C...

October 4, 2023 | Wednesday | News
Pfizer launches Rimegepant in Hong Kong, first market in Asia for migraine management

US-based pharmaceutical company Pfizer has announced the availability of Rimegepant in Hong Kong, the first market ...

October 3, 2023 | Tuesday | News
From global to local – the need to build pharmaceutical self-sufficiency in the Middle East for a sustainable future

While global inflationary pressures are expected to ease this year, experts opine that the pharmaceutical sector may sti...

October 3, 2023 | Tuesday | Opinion
Big Pharma Sets Sights on Middle East

The Middle East is rapidly emerging as a key player in the global life sciences and pharmaceutical industry. With ambiti...

October 3, 2023 | Tuesday | Analysis
JLABS collaborates with EDB to transform Singapore's Life Science Innovation Ecosystem

Johnson & Johnson International (Singapore) Pte. Ltd. has collaborated with the Singapore Economic Development Board...

September 26, 2023 | Tuesday | Company results
New cell therapy facility by Novo Nordisk enters fight against chronic diseases

The Novo Nordisk Foundation has committed up to DKK 950 million (EUR 127 million) to establish a world-cl...

September 21, 2023 | Thursday | News
Everest Medicines signs $125.5 M deal with Kezar Life Sciences for Greater China and other Asian markets

Everest Medicines has entered into a collaboration and license agreement with Kezar Life Sciences to develop and commerc...

September 21, 2023 | Thursday | News
Merck announces two strategic collaborations to strengthen AI-driven drug discovery

Merck, a leading science and technology company, has announced two new strategic drug discovery collaborations aimed at ...

September 20, 2023 | Wednesday | News
Japanese pharma firm Astellas to invest more than €330 M in Ireland facility

Japan headquartered Astellas Pharma has announced its intention to submit a planning application to build a new state-of...

September 18, 2023 | Monday | News
Gilead Sciences appoints new GM for Korea

Gilead Sciences has announced the appointment of Jae Yeon Choi as General Manager (GM), Korea, effective 1st October 202...

September 14, 2023 | Thursday | News
AI to transform all processes in drug development by 2026: CPHI report

The first part of the influential CPHI Annual Report predicts sizeable progress ahead for artificial intelligence (AI)&r...

September 13, 2023 | Wednesday | News